Zdrowie i gospodarka · 03/08/2001

FDA Releases Draft Guidance for Reviewers on Automated Testing Instruments for Blood Establishments

The FDA has made available a draft document outlining the information and approach reviewers should expect when evaluating premarket notifications for automated testing instruments used in blood establishments, with the goal of finalizing the guidance for establishments that manufacture blood and blood components.